International customers, contact your distributor or local Hologic Sales
Representative:
European Representative
Hologic BVBA
Da Vincilaan 5
1930 Zaventem
Belgium
Phone: +32 2 711 46 80
Essential Performance
The MyoSure system has no essential performance.
Electromagnetic Safety Guidance
The following tables provide information on the electromagnetic
environment that the MyoSure Hysteroscopic Tissue Removal System is
capable of operating in safely. Use of this equipement in an enviroment
that exceeds these limits may cause the device to stop working, change
cutting speed, or produce other unknown behavior. It is the responsibility
of the person installing the Hologic MyoSure Hysteroscopic Tissue
Removal System to insure the electromagnetic environment does not
exceed the specification set forth below in Tables 1–4.
Table 1 – Guidance and manufacturer's declaration – electromagnetic
emissions
Guidance and manufacturer's declaration – electromagnetic emissions
The MyoSure Hysteroscopic Tissue Removal System is intended for use in the
electromagnetic environment specified below. The customer or the user of the
MyoSure Hysteroscopic Tissue Removal System should assure that it is used
in such an environment.
Emissions test
Compliance
RF emissions
Group 1
CISPR 11
RF emissions
Class B
CISPR 11
Harmonic emissions
Class A
IEC 61000-3-2
Voltage fluctuations/
Complies
flicker emissions
IEC 61000-3-3
Electromagnetic environment
– guidance
The MyoSure Hysteroscopic
Tissue Removal System uses
RF energy only for its internal
function. Therefore, its RF
emissions are very low and
are not likely to cause any
interference in nearby electronic
equipment.
The MyoSure Hysteroscopic
Tissue Removal System
is suitable for use in all
establishments.
Table 2 – Guidance and manufacturer's declaration – electromagnetic
immunity
Guidance and manufacturer's declaration – electromagnetic immunity
The MyoSure Hysteroscopic Tissue Removal System is intended for use in the
electromagnetic environment specified below. The customer or the user of the
MyoSure Hysteroscopic Tissue Removal System should assure that it is used
in such an environment.
Immunity
IEC 60601
test
test level
Electrostatic
±2 kV, ±4 kV,
discharge
±8 kV Contact
(ESD) IEC
±2 kV,
61000-4-2
±4kV, ±8 kV,
±15 kV, Air
Electrical
±0.5 kV, ±1 kV,
fast
±2 kV for
transient/
power supply
burst IEC
lines
61000-4-4
100kHz
repetition
frequency
Surge
±0.5 kV, ±1 kV
line(s) to
IEC
line(s)
61000-4-5
±0.5 kV, ±1 kV,
±2 kV line(s)
to earth
Voltage
0% U
; 0.5
T
dips, short
cycle at
interruptions
0°, 45°,
and voltage
90°,135°,
variations
180°, 225°,
on power
270° and
supply input
315°
lines
0% U
;
T
IEC
1 cycle and
61000-4-11
70% U
;
T
25/30 cycles
Single phase:
at 0°
0% U
; 250
T
cycles
Power
30 A/m
frequency
50 Hz
(50/60 Hz)
magnetic
field
IEC
61000-4-8
NOTE
U
is the a.c. mains voltage prior to application of the test level.
T
9
Compliance
Electromagnetic
level
environment – guidance
±2 kV, ±4 kV,
Floors should be wood,
±8 kV Contact
concrete, or ceramic tile.
±2 kV,
If floors are covered with
±4kV, ±8 kV,
synthetic material, the
±15 kV, Air
relative humidity should be
at least 30%.
±0.5 kV, ±1 kV,
Mains power quality
±2 kV for
should be that of a typical
power supply
commercial or hospital
lines
environment.
100kHz
repetition
frequency
±0.5 kV, ±1 kV
Mains power quality
differential
should be that of a typical
mode
commercial or hospital
environment.
±0.5 kV, ±1 kV,
±2 kV
common
mode
0% U
; 0.5
Mains power quality
T
cycle at
should be that of a typical
0°, 45°,
commercial or hospital
90°,135°,
environment. If the user of
180°, 225°,
the MyoSure Hysteroscopic
270° and
Tissue Removal System
315°
requires continued
operation during power
0% U
;
T
mains interruptions, it is
1 cycle and
recommended that the
70% U
;
MyoSure Hysteroscopic
T
25/30 cycles
Tissue Removal System
Single phase:
be powered from an
at 0°
uninterruptible power supply.
0% U
; 250
T
cycles
30 A/m
Power frequency magnetic
fields should be at levels
50 Hz
typical for commercial or
hospital environments.
ENGLISH